Terns Pharmaceuticals, Inc. · NASDAQ:TERN
BlackRock, Inc. reported a 6.80% stake in Terns Pharmaceuticals, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 5, 2025
BlackRock, Inc. reported a 6.80% stake in Terns Pharmaceuticals, Inc., 5,743,482 shares, as a passive investor on Dec 31, 2024. Filed Feb 5, 2025 (Schedule 13G/A).
- Stake
- 6.80%
- Shares
- 5,743,482
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.80% | 5,743,482 |
Source
Related
- Terns Pharmaceuticals, Inc.
- BlackRock, Inc.
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026